Eagle Pharmaceuticals

243 articles with Eagle Pharmaceuticals

• Eagle Pharmaceuticals To Hold Conference Call At 8:30 A.M. EST Today To Discuss Licensing Agreement With Teva Pharmaceutical Industries To Commercialize Eagle’s Rapid Infusion Bendamustine

  2/17/2015

• Eagle Pharmaceuticals Announces Change In Fiscal Year End

  1/20/2015

• Eagle Pharmaceuticals Reports Fourth Quarter And Year End 2014 Financial Results

  12/17/2014

• Eagle Pharmaceuticals To Discuss 2014 Fourth Quarter And Year-End Financial Results On December 17, 2014

  12/5/2014

• Eagle Pharmaceuticals To Present At Piper Jaffray 2014 Healthcare Conference

  11/20/2014

• Eagle Pharmaceuticals Reports Positive Outcomes From Clinical Trial Of Bendamustine HCl Product Delivered Via Low-Volume, Rapidly Infused Admixture

  11/10/2014

• Eagle Pharmaceuticals To Present At Stifel 2014 Healthcare Conference

  11/7/2014

• Eagle Pharmaceuticals To Present At 21st Annual NewsMakers In The Biotechnology Industry Investment Conference

  9/23/2014

• Eagle Pharmaceuticals Announces That Teva Pharmaceutical Industries Limited Requests A Motion To Dismiss With Prejudice In Its Bendamustine Patent Infringement Lawsuit

  9/17/2014

• Eagle Pharmaceuticals Reports Third Quarter 2014 Results

  8/11/2014

• Eagle Pharmaceuticals Schedules Third Quarter Earnings Release And Conference Call

  7/30/2014

• FDA Approves Eagle Pharmaceuticals' Ryanodex® For The Treatment Of Malignant Hyperthermia

  7/23/2014

• Eagle PharmaceuticalsReceives Orphan Drug Designation For Lower Volume, Shorter Infusion Time Bendamustine Hydrochloride Product For Chronic Lymphocytic Leukemia And Indolent B-Cell Non-Hodgkin’s Lymphoma

  7/8/2014

• Eagle Pharmaceuticals Receives Tentative Approval For Patented, Ready-to-Dilute Bendamustine Hydrochloride Injection NDA

  7/2/2014

• Eagle Pharmaceuticals To Present At Jefferies and Co. 2014 Global Healthcare Conference

  5/22/2014

• Eagle Pharmaceuticals Reports Second Quarter 2014 Results

  5/14/2014

• Eagle Pharmaceuticals Schedules Second Quarter Earning Release And Conference Call

  5/1/2014

• Eagle Pharmaceuticals To Present At 39th Annual Deutsche Bank Health Care Conference

  4/29/2014

• Eagle Pharmaceuticals’ Exclusive Licensor Granted U.S. Patent For Dantrolene In The Treatment Of Heat Stroke

  4/1/2014

• NDA For Eagle Pharmaceuticals' Orphan Drug Ryanodex® For The Treatment Of Malignant Hyperthermia Accepted By FDA, Priority Review Granted

  3/20/2014